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Abstract
Background: Epidemiologic studies of skin and soft tissue infections (SSTIs) depend upon accurate case
identification. Our objective was to evaluate the positive predictive value (PPV) of electronic medical record data for
identification of SSTIs in a primary care setting.
Methods: A validation study was conducted among primary care outpatients in an academic healthcare system.
Encounters during four non-consecutive months in 2010 were included if any of the following were present in the
electronic health record: International Classification of Diseases, Ninth Revision (ICD-9) code for an SSTI, Current
Procedural Terminology (CPT) code for incision and drainage, or a positive wound culture. Detailed chart review
was performed to establish presence and type of SSTI. PPVs and 95% confidence intervals (CI) were calculated
among all encounters, initial encounters, and cellulitis/abscess cases.
Results: Of the 731 encounters included, 514 (70.3%) were initial encounters and 448 (61.3%) were cellulitis/abscess
cases. When the presence of an ICD-9 code, CPT code, or positive culture was used to identify SSTIs, 617
encounters were true positives, yielding a PPV of 84.4% [95% CI: 81.8–87.0%]. The PPV for using ICD-9 codes alone
to identify SSTIs was 90.7% [95 % CI: 88.5–92.9%]. For encounters with cellulitis/abscess codes, the PPV was 91.5%
[95% CI: 88.9–94.1%].
Conclusions: ICD-9 codes may be used to retrospectively identify SSTIs with a high PPV. Broadening SSTI case
identification with microbiology data and CPT codes attenuates the PPV. Further work is needed to estimate the
sensitivity of this method.
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Background
In recent years, ICD-9 diagnosis codes have been more
commonly used for retrospective identification and clas-
sification of SSTIs from administrative and electronic
health records (EHR).[1-6] Although this is a simple and
straightforward method for case identification, these
data are not collected for research purposes and may be
subject to misclassification. While ICD-9 code validity
has been assessed for other infections and diseases, there
have been no reported evaluations of their use in the
retrospective identification of SSTIs. The inherently sub-
jective nature of various medical diagnoses combined
with extrinsic factors such as human error or delays in
data entry may affect the validity of these codes. The
variability in ICD-9 code validity for identifying specific
diagnoses depends upon the disease studied and clinical
setting, as well as the specific algorithm used for case
identification (i.e., which specific ICD-9 codes were used
and if other clinical data were included).[7-10] Further,
in scenarios where there is no definitive gold standard,
the definition of ‘true’ disease may impact positive pre-
dictive value (PPV).[10] Consequently, it is crucial to
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assess the validity of using diagnosis codes to detect spe-
cific cases of interest, such as SSTI infections.
Since valid methods of case ascertainment are critical to
minimize the effects of misclassification in epidemiologic
and outcomes studies of SSTIs, our primary objectives in
this study were to (1) estimate the PPV of ICD-9 diagnosis
codes for the retrospective identification of SSTIs in an
outpatient primary care setting and (2) determine whether
modifying the SSTI identification algorithm to include
additional diagnostic indicators (i.e., wound culture and
incision and drainage) would improve the precision of pre-
diction results.
Methods
A validation study was conducted among ambulatory
primary care patients at Oregon Health & Science Uni-
versity (OHSU). OHSU is a large academic healthcare
system that includes two hospitals and numerous out-
patient clinics throughout the greater Portland, Oregon
metropolitan area; the OHSU healthcare system has over
750,000 patient encounters annually. The EpicCare EHR
system (Epic Systems) is used for both inpatient and out-
patient encounters throughout this system. For this
study, encounters occurring in January, April, July or
October 2010 in outpatient, non-specialty clinics of the
Family Medicine, Internal Medicine and Pediatrics de-
partments were eligible for inclusion; these months were
selected to be representative of the calendar year and
minimize seasonal or secular variations in the data. Pa-
tient encounters were included if any of the following
criteria were present in the EHR: an SSTI ICD-9 diagno-
sis code [erysipelas: 035; carbuncle and furuncle: 680.x;
cellulitis and abscess: 681.0, 681.00, 681.01, 681.10,
681.9, 682.x; acute lymphadenitis: 683.x; impetigo: 684.x;
other local infections of skin and subcutaneous tissue:
686.x; other specified diseases of hair and hair follicles:
704.8], Current Procedural Terminology (CPT) code for
incision and drainage (IND) [10060/1, 10080/1, 10120/1,
10140, 10160, 10180], or a positive wound or tissue mi-
crobiology culture. Encounters with missing electronic
data were excluded. This study was approved by the
Oregon Health & Science University institutional review
board.
Patient identification and data collection
Data were electronically abstracted from the institution’s
research data warehouse (RDW), a data repository that
stores clinical, laboratory, and administrative data from
the electronic medical record data systems. Study subjects
were identified for inclusion through the RDW. For eli-
gible patients, the following data were collected: demo-
graphics, SSTI ICD-9 codes, CPT codes for IND, wound/
tissue culture results, temperature, encounter dates, and
clinic location.
Data validation and supplemental data collection
A chart review-based validation was performed to confirm
SSTI diagnoses (the classification of SSTIs based on de-
tailed chart review is hereafter referred to as the “gold
standard”). During their assessment, reviewers determined
the appropriate diagnosis and associated ICD-9 diagnosis
code for each encounter using physician notes to ascertain
the existence of an SSTI and specific type of infection by
reviewing clinician notes pertaining to the body site(s) of
infection, presence of erythema, purulence, spontaneous
drainage, crusting, discoloration, identification and num-
ber of nodules/papules, and follicular involvement. Patient
characteristics and past medical history were also consid-
ered. In cases where incision and drainage was performed
or spontaneous drainage was noted, the infection was con-
sidered to be purulent. Reviewers also used provider notes
and other encounter data to determine whether the en-
counter was an initial or follow-up visit for the SSTI. If
minimal documentation was present, the provider’s diag-
nosis (i.e., SSTI based on ICD-9 code) was considered
valid. To reduce inter-rater variability, all reviewers re-
ceived study-specific training and standardized documen-
tation for assessing SSTI diagnoses were developed based
upon clinical infectious disease texts.[11-14] Reviewers
extracted data into a Microsoft Access form (2007,
Microsoft Corporation) to standardize the collection of
data and the information used to confirm the diagnosis.
Medical records were reviewed independently by at least
two members of the study team to further improve reli-
ability. If reviewers disagreed, a third reviewer served as
the tie-breaker. Data extracted during the detailed chart
review were stored in a Microsoft Access database.
Data analysis
We created two algorithms for the identification of any
SSTI and one algorithm for the identification of only cel-
lulitis/abscess using EHR data. For each algorithm, the
PPV was calculated using the chart review-based SSTI
diagnosis as the gold standard. The three different algo-
rithms were as follows: (1) presence of any SSTI ICD-9
[035, 680–684, 686.x, 704.8] or IND CPT code [10060/1,
10080/1, 10120/1, 10140, 10160, 10180], or a positive
wound culture; (2) presence of any SSTI ICD-9 code; (3)
presence of SSTI ICD-9 codes for cellulitis/abscess
[681.00, 681.0, 681.1, 681.10, 681.9, 682.x]. For cellulitis/
abscess diagnoses, an additional PPV was calculated where
true positives were both correctly coded and body-site
specific (e.g., a leg abscess confirmed by chart review was
correctly identified with the ICD-9 code specifying cellu-
litis and abscess of leg – 682.6). Table 1 describes the
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different SSTI identification algorithms for which PPVs
were calculated and the criteria used to identify true posi-
tives. All PPVs were calculated using both the total study
sample and initial (i.e., not follow-up) encounters only.
Descriptive statistics were calculated to describe demo-
graphic information such as age and gender, initial visit
status, and encounter department. All data were analyzed
with SAS (version 9.2, SAS Corporation, Cary NC).
Results
Through the electronic data warehouse, 737 of 46,045
encounters were identified that met all inclusion criteria.
After chart review, 6 were excluded due to missing data
in the EHR. Thus 731 encounters were included in the
final analysis dataset. Of these, 54.4% were for female
patients and the mean patient age was 39.1 years (stan-
dard deviation, ±23.7 years); 70.3% of the encounters
were the initial visit for diagnosis and treatment of the
SSTI (Table 2). Family medicine had the largest propor-
tion of visits (61.4%) of the three outpatient departments
and 13.2% of those visits were in patients under age 18.
Cellulitis/abscess was the most common SSTI (68.3%)
identified through chart review, followed by folliculitis
(8.9%) and impetigo (8.9%), carbuncle/furuncle (6.0%),
and other SSTIs (7.8%). Of the 100 wound cultures
performed among the 617 SSTIs confirmed through
chart review, 66 (66.0%) were positive cultures. S. aureus
Table 1 Description of skin and soft tissue infection
identification algorithms evaluated
Test criteria Definition of true positive
Any of the following criteria: Any SSTI present
SSTI ICD-9 code
Incision and drainage CPT code
Positive wound culture
SSTI ICD-9 code Any SSTI present
Cellulitis/Abscess ICD-9 code Cellulitis and/or abscess present
Cellulitis/Abscess ICD-9 code,
body site specific
Cellulitis and/or abscess present
at body site indicated by ICD-9 code
Note: SSTI, skin and soft tissue infection; ICD-9, International Classification of
Diseases, Ninth Revision; CPT, current procedural terminology.
Table 2 Patient demographics and encounter characteristics
Family medicine Internal medicine Pediatrics Overall
(n=449) (n=163) (n=119) (n=731)
Age, mean years ± SD 42.9 ± 21.0 53.1 ± 15.0 5.5 ± 5.4 39.1 ± 23.7
Female sex 257 (57.2) 88 (54.0) 53 (44.5) 398 (54.4)
Race
White 413 (92.0) 145 (89.0) 93 (78.2) 651 (89.1)
Black 11 (2.4) 11 (6.7) 7 (5.9) 29 (4.0)
Asian/Pacific Islander 13 (2.9) 2 (1.2) 11 (9.2) 26 (3.6)
Other 5 (1.1) 4 (2.5) 6 (5.0) 15 (2.1)
Unknown/not reported 7 (1.6) 1 (0.6) 2 (1.7) 10 (1.4)
Hispanic ethnicity 8 (1.8) 1 (0.6) 26 (21.8) 35 (4.8)
Initial encounter for SSTI 290 (64.6) 115 (70.6) 109 (91.6) 514 (70.3)
Encounter month
January 116 (25.8) 27 (16.6) 27 (22.7) 170 (23.3)
April 98 (21.8) 40 (24.5) 42 (35.3) 180 (24.6)
July 116 (25.8) 48 (29.4) 30 (25.2) 194 (26.5)
October 119 (26.5) 48 (29.4) 20 (16.8) 187 (25.6)
ICD-9 code for SSTI 449 (100.0) 163 (100.0) 119 (100.0) 731 (100.0)
CPT code for IND 61 (13.6) 11 (6.7) 4 (3.4) 76 (10.4)
Positive wound culture 62 (13.8) 16 (9.8) 25 (21.0) 103 (14.1)
SSTI Identification Criteria
ICD-9 or CPT code or positive culture 449 (100.0) 163 (100.0) 119 (100.0) 731 (100.0)
ICD-9 SSTI code only 412 (91.8) 147 (90.2) 110 (92.4) 669 (91.5)
Cellulitis/Abscess ICD-9 code 305 (67.9) 101 (62.0) 42 (35.3) 448 (61.3)
Cellulitis/Abscess ICD-9 code, body site specific 267 (59.5) 86 (52.8) 35 (29.4) 388 (53.1)
Note: Data are no. (%), unless otherwise indicated. The “Other” race category includes Native Americans, Alaskan Natives, and individuals reporting multiple races.
SD, standard deviation, SSTI, Skin and soft tissue infection,ICD-9, International Classification of Diseases, 9th Revision, CPT, Current Procedure Terminology, IND,
Incision and drainage.
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was the most frequently isolated pathogen. Among ini-
tial encounters for SSTIs, antibiotic treatment alone was
prescribed in 68.4% of visits, IND alone was performed
in 3.9%, IND and antibiotics were given in 11.9%, and
neither IND nor antibiotic treatment was given in 15.8%
of encounters. Trimethoprim/sulfamethoxazole (28.0%),
cephalexin (19.2%) and mupirocin (16.2) were the most
commonly prescribed antibiotics.
“True” SSTIs were confirmed in 617 of the encounters,
a prevalence of 1.3%. Table 3 presents the positive pre-
dictive value for each of the SSTI identification algo-
rithms calculated among all encounters and among only
initial encounters for the SSTI. The highest PPV was for
detecting cellulitis/abscess based on ICD-9 codes at
(PPV = 91.5%; 95% CI: 88.9-94.1%), and the lowest was
for the identification cellulitis/abscess specific to body
site (PPV = 52.6%; 95% CI: 47.6-57.6%). PPVs were lower
overall when the SSTI identification algorithm was re-
stricted to initial visits.
Discussion
This study demonstrated that ICD-9 codes may be used
to identify SSTIs in primary care outpatient settings with
a high PPV. While we had hypothesized that broadening
our SSTI identification algorithm to utilize additional
clinical data (i.e., wound cultures and procedure codes)
would improve the performance of our algorithm, of the
61 additional encounters included with these expanded
criteria, only 10 were true SSTIs. Consequently, inclu-
sion of these data resulted in a reduction in PPV com-
pared to an algorithm based only on ICD-9 codes.
Our study is the first to assess the PPV for EHR-based
algorithms for the identification of SSTIs in a primary care
outpatient setting. An earlier study by Tracy et al. evalua-
ted the PPV of clinical cultures positive for S. aureus for
the identification of non-invasive S. aureus infections in a
Veterans Affairs patient population. While this study
noted a high PPV for SSTIs (PPV = 95%; 95% CI: 86-98%),
it is important to note this approach does not detect un-
cultured infections [15]. In our primary care patient sam-
ple, only 36 (5%) of patients had a positive culture for S.
aureus. Thus, depending on the research question, an
ICD-9 based method of case identification may more ap-
propriately capture cases of SSTIs for study.
The range of PPVs observed across the different algo-
rithms illustrates the importance of validation. In this study,
we measured high PPVs using ICD-9 codes to detect SSTIs
which means in turn that few patients are likely to be mis-
classified as an SSTI case. Still, because our study did not
include patients without SSTI ICD-9 codes, we were unable
to measure sensitivity. As a result, the false negative rate
(i.e., misclassifying true SSTIs as non-cases) by applying an
algorithm based on ICD-9 codes remains unknown. It
should also be noted that, as PPV varies with prevalence,
this validation study may not be generalizable to other pa-
tient populations. Also, in this patient population, providers
coded infections themselves within the EpicCare EHR sys-
tem and thus PPV may vary in settings where providers do
not perform the coding or in which the method of coding
(e.g., the EHR system) varies. Our study also did not ad-
dress more complicated/severe infections such as diabetic
foot infections, infected pressure ulcers, or surgical site in-
fections. Finally, given that this was a retrospective study,
the gold standard was based upon chart review and thus
limited by the level of detail in the provider’s notes.
Of note, our study revealed that after evaluation of
treatment patterns for true SSTIs, 33.0% of encounters
(15.8% of initial encounters) received no antibiotic treat-
ment or IND. While smaller, less severe SSTIs may not
require medical intervention, the relatively large propor-
tion of untreated patients may reflect the inclusion of
follow-up visits in this study.
Conclusion
This study demonstrates that algorithms which use ICD-9
codes to detect SSTIs can achieve a high PPV in ambula-
tory primary care settings. While the number of SSTI
cases that would not be detected by this approach was un-
measured, the ICD-9 based SSTI identification method
would likely capture those patients with a single diagnosis
for their visit. Thus, these diagnosis codes may be useful
in facilitating internal process improvement and quality
initiatives as well as future studies exploring both the epi-
demiology and outcomes associated with SSTIs.
Table 3 Positive predictive values for each skin and soft tissue infection identification algorithm
Initial visits All visits
SSTI identification criteria True positives/
encounters
PPV (95% CI) True positives/
encounters
PPV (95% CI)
ICD-9 or CPT code or positive culture 413/514 80.4 (76.9-83.8) 617/731 84.4 (81.8-87.0)
ICD-9 SSTI code only 404/455 88.8 (85.9-91.7) 607/669 90.7 (88.5-92.9)
Cellulitis/Abscess ICD-9 code 228/254 89.8 (086.0-93.5) 410/448 91.5 (88.9-94.1)
Cellulitis/Abscess ICD-9 code, body site specific 116/214 54.2 (47.5-60.9) 204/388 52.6 (47.6-57.6)
Note: SSTI, skin and soft tissue infection; ICD-9, International Classification of Diseases, Ninth Revision; CPT, current procedural terminology; CI, confidence interval.
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